In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This briefing identifies some of the key findings and implications for policy makers and advocates from this research.
Martin Jelsma, Neil Boister, David Bewley-Taylor, Malgosia Fitzmaurice, John Walsh
15 March 2018
Legal tensions are growing within the international drug control regime as increasing numbers of member states move towards or seriously consider legal regulation of the cannabis market for non-medical purposes. Amongst reform options not requiring consensus, inter se modification appears to be the most ‘elegant’ approach and one that provides a useful safety valve for collective action to adjust a treaty regime arguably frozen in time.
Cannabis (or marihuana) is one of the most widely consumed psychoactive substances in the world. According to the United Nations World Drug Report, 183 million people, or 3.8% of the world’s population, used cannabis in 2014. Its cultivation was also reported by 129 countries. Cannabis is subject to the United Nations System for International Control of Narcotic Drugs and Psychotropic Substances (hereafter “drugs”) and is the most widely consumed of all the drugs. According to that control system, cannabis is among the substances with the strictest legal status; they are the most prohibited, supposedly because of the harm they cause and their lack of medical usefulness.
Paraguay is the principal producer of cannabis in South America. Despite its importance as a supplier of cannabis in South America, there has been a surprising absence of serious studies of its impact on its own society, and on the play of offer and demand in neighbouring countries.
As an increasing number of jurisdictions consider whether and how to legalize and regulate access to cannabis, tensions are growing between these initiatives and countries’ obligations under the UN drug control conventions. A groundbreaking new report produced by a coalition of legal and drug policy experts offers strategies for countries exploring regulatory approaches to cannabis to do so in ways that ensure that their domestic reforms align with their international legal obligations.
Mexico City — Today, the Research Consortium on Drugs and the Law (Colectivo de Estudios Drogas y Derecho, CEDD) will release a series of new studies showing that mass incarceration for nonviolent drug offenses has increased across the region.
The Organization of American States (OAS) adopted by acclamation a resolution that underscores "the importance of hemispheric and international cooperation to jointly tackling the world drug problem, by promoting and strengthening comprehensive policies and, where appropriate, the modernization and professionalization of government institutions."
Cannabis is the most widely produced and consumed illicit substance globally. A significant number of states have long engaged in soft defection from the UN drug control regime in relation to tolerant policies on the personal possession, cultivation and use of cannabis. Recently, there has been growing debate within political circles on the benefits of regulated cannabis markets. This has been driven by a number of factors, including the continuing illegality of supply, the associated and often violent involvement of criminal elements and the use of finite criminal justice resources. In this section you will find an overview of our most recent blogs on the issue.
The current trend towards legal regulation of the cannabis market has become irreversible and requires an urgent dialogue by UN member states on the best models for protecting people’s health and safety, argues a new report. The question facing the international community today is no longer whether there is a need to revise the UN drug control system, but rather when and how to do it.
As the UN International Narcotics Control Board (INCB) launches its annual report on Tuesday, 4 March, amidst an unprecedented crisis in the international drug control regime, leading drug policy reform experts have called on the INCB and related UN institutions to urgently open up a constructive dialogue on international drug policy reform.
Uruguay’s senate voted today (10 December) to approve the world’s first national legal framework regulating the cultivation, trade and consumption of cannabis for medical, industrial as well as recreational purposes. The historical vote is expected to inspire and spread cannabis reform initiatives around the world and to have a major impact on upcoming UN-level drug policy evaluations.
The signatory organisations below wish to congratulate the Uruguayan Deputies and Senators that have voted in favour of the law regulating marijuana, and the organisations that have been pushing for drug policy reform for years.Cannabis regulation is a positive step to try and tackle drug-related violence in our countries.
We, the undersigned human rights organizations, address you on this Fourth Meeting of Ministers Responsible for Public Security (MISPA) to follow up on the call upon governments to revise the orientation of drug policies that are being implemented in the Americas. This request for the governments took place during the 43rd Session of the OAS General Assembly which took place last June.
The U.S. Justice Department’s new guidance on federal marijuana enforcement priorities clears the way for Colorado and Washington state to pursue the legalized, regulatory approaches to marijuana that voters approved by wide margins in November 2012 ballot initiatives. This is a welcome step that provides an enormous opportunity for learning about how to improve our drug policies, according to the Washington Office on Latin America (WOLA).
The bill will now be taken up in Uruguay’s Senate—where the governing Frente Amplio coalition also holds a majority—and could soon arrive on the desk of President José Mujica, who has supported the proposal since its introduction in 2012.
On May 17, 2013, the Secretary General of the Organisation of American States (OAS), José Miguel Insulza, met with Colombian President Juan Manuel Santos to share the results of the hemispheric review of drug policies. This task was entrusted to him by the Heads of States of the Americas at the Sixth Americas Summit held in April 2012 in Cartagena, Colombia.
Washington, D.C.—This Friday, May 17, in Bogotá, Colombia, Organization of American States (OAS) Secretary General José Miguel Insulza will present Colombian President Juan Manuel Santos with the outcomes of the hemispheric drug policy review that was mandated by the heads of state at the 2012 Summit of the Americas in Cartagena.
This Friday, May 17, in Bogotá, Colombia, Organization of American States (OAS) Secretary General José Miguel Insulza will present Colombian President Juan Manuel Santos with the outcomes of the hemispheric drug policy review that was mandated by the heads of state at the 2012 Summit of the Americas in Cartagena.